Free Trial

Amdocs Limited $DOX Shares Purchased by Charles Schwab Investment Management Inc.

Amdocs logo with Computer and Technology background

Key Points

  • Charles Schwab Investment Management Inc. increased its holdings in Amdocs Limited by 5% during the first quarter, acquiring an additional 10,766 shares, resulting in ownership of approximately 0.20% of the company valued at $20.5 million.
  • Amdocs Limited recently declared a quarterly dividend of $0.527 per share, with a dividend yield of 2.4% and a payout ratio of 42.80%.
  • The company has received positive ratings from analysts, with a consensus rating of "Buy" and a target price of $105.33, indicating strong market confidence in Amdocs' performance.
  • Want stock alerts on Amdocs? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Charles Schwab Investment Management Inc. boosted its holdings in Amdocs Limited (NASDAQ:DOX - Free Report) by 5.0% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 224,076 shares of the technology company's stock after acquiring an additional 10,766 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.20% of Amdocs worth $20,503,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Cornerstone Planning Group LLC acquired a new position in shares of Amdocs in the 1st quarter worth approximately $27,000. AdvisorNet Financial Inc boosted its holdings in Amdocs by 382.9% during the first quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company's stock worth $31,000 after buying an additional 268 shares in the last quarter. NBC Securities Inc. bought a new stake in Amdocs during the first quarter worth approximately $31,000. Cullen Frost Bankers Inc. acquired a new position in Amdocs in the first quarter worth approximately $39,000. Finally, Tower Research Capital LLC TRC increased its holdings in shares of Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after buying an additional 208 shares in the last quarter. 92.02% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DOX has been the subject of several research reports. Wolfe Research assumed coverage on Amdocs in a research note on Tuesday, July 8th. They set an "outperform" rating for the company. Wall Street Zen raised Amdocs from a "hold" rating to a "buy" rating in a report on Sunday, August 10th. Four analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and a consensus target price of $105.33.

Get Our Latest Report on DOX

Amdocs Stock Performance

Shares of DOX stock opened at $86.61 on Friday. The company has a market capitalization of $9.78 billion, a price-to-earnings ratio of 17.57, a P/E/G ratio of 1.59 and a beta of 0.51. Amdocs Limited has a 1-year low of $78.61 and a 1-year high of $95.41. The company has a current ratio of 1.22, a quick ratio of 1.16 and a debt-to-equity ratio of 0.23. The stock's fifty day simple moving average is $89.22 and its 200-day simple moving average is $88.76.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The technology company reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%.The firm had revenue of $1.14 billion during the quarter, compared to the consensus estimate of $1.13 billion. During the same period in the prior year, the business earned $1.62 EPS. The business's revenue for the quarter was down 8.4% on a year-over-year basis. On average, sell-side analysts predict that Amdocs Limited will post 6.21 earnings per share for the current fiscal year.

Amdocs Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be issued a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Tuesday, September 30th. Amdocs's dividend payout ratio (DPR) is currently 42.80%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Articles

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amdocs Right Now?

Before you consider Amdocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.

While Amdocs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines